Antiretroviral coverage in Africa improved by donors and price cuts

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 618, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Possible Drug–Metabolism Interactions of Medicinal Herbs with Antiretroviral Agents

By van den Bout-van den Beukel Carolien   Koopmans Peter   van der Ven André   De Smet Peter   Burger David  

Drug Metabolism Reviews, Vol. 38, Iss. 3, 2006-06 ,pp. : 477-514

Informa Healthcare

Access to resources Recommend Favorite

Persistence of drug-resistant HIV-1 and possible implications for antiretroviral therapy

By Metzner Karin J  

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 377-391

Future Medicine

Access to resources Recommend Favorite

GlaxoSmithKline have announced new price reductions for HIV drugs for the world's poorest countries.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 548, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Merck & Co. has substantially cut the price of 2 of its antiretroviral agents in Mexico

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite